OMADA HEALTH INC Stock Price, News & Analysis

Omada Health (Nasdaq: OMDA) has released groundbreaking research demonstrating significant cost savings from their virtual physical therapy program. The study compared virtual PT to in-person physical therapy for musculoskeletal (MSK) conditions using claims data from July 2019 to May 2023.

Key findings show that Omada's virtual MSK program achieved median per-member-per-month savings exceeding $100 in the first six months, with median gross MSK savings per member over $1,000 at both six and 12 months. The program delivered a positive ROI of 1.8x at both intervals, while reducing total medical care utilization and MSK-related costs compared to traditional in-person therapy.

This research is particularly significant as MSK conditions affect over 50% of U.S. adults and cost the healthcare system more than $420 billion in 2018, surpassing costs for diabetes and heart disease.

Omada Health (Nasdaq: OMDA), a virtual between-visit healthcare provider, will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference in New York. The company's senior management will engage in a fireside chat on September 9, 2025, at 5:35 pm ET. Investors can access the webcast through the company's investor relations website, with a replay available after the event.

Omada Health (NASDAQ:OMDA), a virtual between-visit healthcare provider, reported strong Q2 2025 financial results with revenue of $61 million, up 49% year-over-year. The company achieved significant member growth of 52% to 752,000 members and improved its financial metrics across the board.

Key financial highlights include gross margin improvement to 66% from 60% in Q2 2024, reduced net loss to $5 million from $11 million, and adjusted EBITDA loss of $0.2 million compared to $6.8 million loss year-over-year. The company maintains a strong cash position of $223 million.

Omada provided FY2025 guidance with revenue expected between $235-241 million and adjusted EBITDA loss of $9-5 million. The company also fully repaid its term loan facility and revolving credit line totaling $31.4 million ahead of schedule.

Omada Health (Nasdaq: OMDA), a virtual between-visit healthcare provider, has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close.

The company will host a conference call to discuss the results at 4:30 PM ET on the same day. Participants can pre-register for the call, and a live audio webcast will be available on the company's investor relations website. The replay will be accessible for approximately 12 months following the call.

Omada Health (OMDA) has released promising data demonstrating the effectiveness of their GLP-1 companion program in improving medication persistence and weight loss outcomes. The analysis of 1,124 members showed significantly higher persistence rates for GLP-1 medications - 94% through 12 weeks and 84% through 24 weeks, compared to previous real-world studies showing rates between 33-80%. Members who remained on their medication through 24 weeks achieved an average weight loss of 12.1%, compared to 7.4% for those who discontinued early. The program provides targeted support including dose titration guidance, side effect management, nutrition advice, and exercise specialist support. These results suggest Omada's enhanced care track can help patients achieve clinical trial-level outcomes in real-world settings, potentially leading to reduced cardiometabolic disease risk.